^
    Apply
    A Phase Ia/Ib Clinical Trial of IBI360 Monotherapy or in Combination With Sintilimab and (or) Chemotherapy in Advanced or Metastatic Solid Tumors (NCT05043298)
    Phase 1a/1b
    Innovent Biologics (Suzhou) Co. Ltd.
    Recruiting
    Last update posted :
    09/22/2022
    Initiation :
    10/27/2021
    Primary completion :
    03/25/2024
    Completion :
    06/18/2024
    HER-2 • CLDN18
    |
    HER-2 negative • CLDN18.2 expression
    |
    Tyvyt (sintilimab) • IBI360